Top Clinical Trials companies in India by Return on Assets (ROA)
India
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
36.13%
|
March 31, 2024 | USD 1.12 | -4.46% |
|
India |
|
| 2 |
35.16%
|
Dec. 31, 2023 | USD 61.92 | -0.63% |
|
India |
|
| 3 |
25.30%
|
June 30, 2024 | USD 60.92 | -1.55% |
|
India |
|
| 4 |
23.13%
|
March 31, 2024 | USD 339.25 | -0.02% |
|
India |
|
| 5 |
20.10%
|
March 31, 2024 | USD 14.65 | -2.48% |
|
India |
|
| 6 |
18.12%
|
March 31, 2024 | USD 25.55 | -4.35% |
|
India |
|
| 7 |
16.59%
|
March 31, 2024 | USD 24.47 | -2.67% |
|
India |
|
| 8 |
16.37%
|
March 31, 2024 | USD 167.70 | 3.37% |
|
India |
|
| 9 |
16.29%
|
March 31, 2024 | USD 2.63 | -4.64% |
|
India |
|
| 10 |
15.99%
|
March 31, 2024 | USD 28.60 | -0.29% |
|
India |
|
| 11 |
14.98%
|
March 31, 2024 | USD 86.25 | -0.49% |
|
India |
|
| 12 |
14.37%
|
March 31, 2024 | USD 13.95 | -1.21% |
|
India |
|
| 13 |
13.84%
|
March 31, 2024 | USD 19.18 | 0.81% |
|
India |
|
| 14 |
13.32%
|
March 31, 2024 | USD 12.77 | -3.16% |
|
India |
|
| 15 |
13.23%
|
March 31, 2024 | USD 7.07 | -1.30% |
|
India |
|
| 16 |
13.18%
|
March 31, 2024 | USD 11.02 | -2.61% |
|
India |
|
| 17 |
13.04%
|
March 31, 2024 | USD 48.55 | -2.16% |
|
India |
|
| 18 |
12.93%
|
March 31, 2024 | USD 8.27 | -6.12% |
|
India |
|
| 19 |
12.60%
|
March 31, 2024 | USD 16.67 | -0.55% |
|
India |
|
| 20 |
12.37%
|
March 31, 2024 | USD 5.26 | -2.10% |
|
India |
|
| 21 |
11.70%
|
March 31, 2024 | USD 3.05 | -1.72% |
|
India |
|
| 22 |
11.62%
|
March 31, 2024 | USD 17.25 | -19.71% |
|
India |
|
| 23 |
11.00%
|
March 31, 2024 | USD 36.49 | -1.65% |
|
India |
|
| 24 |
10.99%
|
March 31, 2024 | USD 8.89 | -0.43% |
|
India |
|
| 25 |
10.35%
|
March 31, 2024 | USD 2.77 | -8.82% |
|
India |
|
| 26 |
10.25%
|
March 31, 2024 | USD 12.17 | 3.64% |
|
India |
|
| 27 |
9.55%
|
March 31, 2024 | USD 10.15 | 0.53% |
|
India |
|
| 28 |
8.62%
|
March 31, 2024 | USD 0.79 | -11.26% |
|
India |
|
| 29 |
8.29%
|
March 31, 2024 | USD 8.42 | -0.78% |
|
India |
|
| 30 |
8.22%
|
March 31, 2024 | USD 20.54 | -1.93% |
|
India |
|
| 31 |
7.98%
|
March 31, 2024 | USD 24.79 | -1.08% |
|
India |
|
| 32 |
7.88%
|
March 31, 2024 | USD 4.72 | -1.03% |
|
India |
|
| 33 |
7.68%
|
March 31, 2024 | USD 2.52 | -4.77% |
|
India |
|
| 34 |
7.34%
|
March 31, 2024 | USD 6.50 | -2.02% |
|
India |
|
| 35 |
7.25%
|
March 31, 2024 | USD 16.89 | -2.20% |
|
India |
|
| 36 |
7.14%
|
March 31, 2024 | USD 10.29 | -2.30% |
|
India |
|
| 37 |
7.05%
|
March 31, 2024 | USD 4.63 | -2.34% |
|
India |
|
| 38 |
7.04%
|
March 31, 2024 | USD 13.45 | -0.86% |
|
India |
|
| 39 |
6.86%
|
March 31, 2024 | USD 2.04 | -1.99% |
|
India |
|
| 40 |
6.26%
|
March 31, 2024 | USD 0.21 | -1.97% |
|
India |
|
| 41 |
6.22%
|
March 31, 2024 | USD 1.71 | 0.29% |
|
India |
|
| 42 |
6.08%
|
March 31, 2024 | USD 3.67 | -1.37% |
|
India |
|
| 43 |
5.99%
|
March 31, 2024 | USD 4.33 | -0.95% |
|
India |
|
| 44 |
5.93%
|
March 31, 2024 | USD 14.90 | -6.51% |
|
India |
|
| 45 |
5.56%
|
March 31, 2024 | USD 16.07 | -4.58% |
|
India |
|
| 46 |
4.98%
|
March 31, 2024 | USD 0.89 | -2.68% |
|
India |
|
| 47 |
4.93%
|
March 31, 2024 | USD 16.55 | -3.58% |
|
India |
|
| 48 |
4.82%
|
March 31, 2024 | USD 2.41 | -2.63% |
|
India |
|
| 49 |
4.55%
|
March 31, 2024 | USD 4.07 | -0.77% |
|
India |
|
| 50 |
3.86%
|
March 31, 2024 | USD 1.19 | -2.10% |
|
India |
Frequently Asked Questions
-
Which Clinical Trials company in India has the highest Return on Assets (ROA) ?
The Clinical Trials company in India with the highest Return on Assets (ROA) is Ind-Swift Laboratories Limited (NSE: INDSWFTLAB.NS) at 36.13%.
-
Which Clinical Trials company in India has the lowest Return on Assets (ROA) ?
The Clinical Trials company in India with the lowest Return on Assets (ROA) is TAKE Solutions Limited (NSE: TAKE.NS) at -135.77%.
-
What are the top 10 Clinical Trials companies in India by Return on Assets (ROA) ?
The top 10 Clinical Trials companies in India by Return on Assets (ROA) are Ind-Swift Laboratories Limited, Sanofi India Limited, Procter & Gamble Health Limited, Abbott India Limited, NATCO Pharma Limited, Concord Biotech Limited, GlaxoSmithKline Pharmaceuticals Limited, Neuland Laboratories Limited, Wanbury Limited and Mankind Pharma Limited.
-
What are the bottom 10 Clinical Trials companies in India by Return on Assets (ROA) ?
The bottom 10 Clinical Trials companies in India by Return on Assets (ROA) are TAKE Solutions Limited, Sun Pharma Advanced Research Company Limited, Suven Life Sciences Limited, Solara Active Pharma Sciences Limited, Krebs Biochemicals & Industries Limited, Bajaj HealthCare Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Mangalam Drugs & Organics Limited and Sequent Scientific Limited.
